Aurélie Caye
Université Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Robert-Debré(FR)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Protein Tyrosine Phosphatases, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → The MLL recombinome of acute leukemias in 2017(2017)679 cited
- → Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network(2015)188 cited
- → Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients(2018)174 cited
- → An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions(2013)152 cited
- → Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis(2014)142 cited
- → Juvenile myelomonocytic leukaemia and Noonan syndrome(2014)134 cited
- → IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951